Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours - Global

Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours

The study will compare the difference between lanreotide Autogel and placebo on progression free survival in patients who have an endocrine tumour in the pancreas or intestines.

En rapport Clinical Trials